Answers are grounded in this paper and cite their sources.
cutoff value of ≤40, 90% sensitivity was achieved for urine-based hrHPV testing. Agreement between results for urine samples and self-collected cervicovaginal samples (kappa = 0.58) or provider-collected cervical samples (kappa = 0.54) was moderate. Urine-based hrHPV testing may be a promising approach to improve cervical cancer screening coverage, especially among women with limited access to health care.
No takes yet. Share an insight, caveat, or question.
Rohner et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: